Teva Pharmaceutical Industries Limited (TEVJF)
OTCMKTS
· Delayed Price · Currency is USD
19.31
0.00 (0.00%)
At close: May 23, 2025
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
$449,081
Profits / Employee
-$34,757
Market Cap
20.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35,686 | -786 | -2.16% |
Dec 31, 2023 | 36,472 | 1,347 | 3.83% |
Dec 31, 2022 | 35,125 | -854 | -2.37% |
Dec 31, 2021 | 35,979 | -2,393 | -6.24% |
Dec 31, 2020 | 38,372 | -1,667 | -4.16% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Teva Pharmaceutical Industries News
- 6 days ago - Why Investors Should Watch Teva Despite Regional Risks - Seeking Alpha
- 7 days ago - Teva Announces Increase of the Maximum Tender Amount of its Debt Tender Offer and Increases to Pool Tender Caps for Pool 2 Notes and Pool 3 Notes - GlobeNewsWire
- 9 days ago - Teva announces upsizing and pricing of $2.3B senior notes - Seeking Alpha
- 9 days ago - Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt - GlobeNewsWire
- 9 days ago - Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy - GlobeNewsWire
- 10 days ago - Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031 - GlobeNewsWire
- 10 days ago - Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes - GlobeNewsWire
- 14 days ago - Moody’s Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy - Financial Post